Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
123I
10%
123I-MIBG
100%
131I-metaiodobenzylguanidine
10%
18F-MFBG
100%
Acquisition Time
10%
After Injection
10%
Body Clearance
10%
Catecholamines
10%
Cell Uptake
10%
Clinical Limitations
10%
Concentration of Measure
10%
Diagnostic Imaging
10%
Ex Vivo Tissues
10%
Expression Level
20%
High Sensitivity
10%
Image Acquisition
10%
In Vivo Imaging
10%
In Vivo Uptake
10%
Iodine-131 (131I)
10%
Low Affinity
10%
Neuroblastoma
100%
Neuroblastoma Cell Line
20%
Neuroendocrine Tumor
10%
Norepinephrine Transporter
100%
Normal Physiology
10%
Patient Radiation Exposure
10%
Pharmacokinetics
10%
Positron Emission Tomography
20%
Radioactivity Concentration
10%
Radiopharmaceuticals
10%
Same-day
10%
Scintigraphy
10%
Single-photon Emission Computed Tomography Imaging
10%
SK-N-BE(2)
10%
Small Lesions
10%
Transporter Expression
20%
Tumor
10%
Tumor Uptake
10%
Tumor-to-background Ratio
10%
Uptake Assay
10%
Uptake Studies
10%
Western Blot
10%
Whole-body
10%
Xenograft
20%
Medicine and Dentistry
(3 Iodobenzyl)guanidine
100%
Catecholamine Uptake
10%
Diagnostic Imaging
10%
Fluorine-18
100%
Ganglioneuroblastoma
100%
In Vitro
20%
Iodine 123
100%
Iodine 131
20%
Neoplasm
30%
Neuroblastoma Cell Line
20%
Neuroendocrine Tumor
10%
Noradrenalin
10%
Norepinephrine Transporter
100%
Pharmacokinetics
10%
Positron Emission Tomography
20%
Radiation Exposure
10%
Radiopharmaceutical
10%
Scintigraphy
10%
Single-Photon Emission Computed Tomography
10%
Uptake Assay
10%
Western Blot
10%
Xenograft
20%